申请人:Harris, III Ralph New
公开号:US20120157494A1
公开(公告)日:2012-06-21
Compounds of the formula I:
or pharmaceutically acceptable salts thereof, wherein the variables are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of diseases associated with the P2X7 purinergic receptor.
式I的化合物:或其药用可接受盐,其中变量如本文所定义。还公开了制备这些化合物的方法,并将这些化合物用于治疗与P2X7嘌呤受体相关的疾病。